Hemoglobin A1c (HbA1c)
| Product Name | Hemoglobin A1c |
| Source | Human Erythrocytes |
| Catalogue Number | 325-10 |
| Purity | > 96% (HPLC) |
| Form | Liquid |
| Protein | > 1.0 mg/mL (OD415nm, E=7) |
| Formulation | Frozen solution in proprietary buffer formulation pH 8.0, and dispensed on the basis of HbA1c, not total hemoglobin. |
| Appearance | Clear, red frozen solution |
| Related Products | 338-10 – Hemoglobin from human red blood cells 325-09 – Hemoglobin A1c from human red blood cells – Control Grade 991-09 – Red Blood Cells from human blood |
| Storage | -20°C |
| Recertification | 5 years |
| Synonyms | HbA1c, Glycohemoglobin, Glycated hemoglobin |
| UNSPSC code | 51131907 |
Lee Biosolutions is the leading producer and supplier of human RBC Hemoglobin A1c (HbA1c) protein used for research and diagnostic manufacturing, as a glucose indicator and diabetic marker.
Custom preparations, technical support, bulk quantities and aliquoting available, email Info@leebio.com for more details.
Human Hemoglobin A1c is a form of hemoglobin which is measured primarily to identify the average plasma glucose concentration over prolonged periods of time. It is formed in a non-enzymatic glycation pathway by hemoglobin's exposure to plasma glucose.
Normal levels of glucose produce a normal amount of glycated hemoglobin. As the average amount of plasma glucose increases, the fraction of glycated hemoglobin increases in a predictable way. This serves as a marker for average blood glucose levels over the previous months prior to the measurement.
Lee Biosolutions, Inc
